+92-(3)-111-0-LIVEN
info@liven-pharma.com https://www.liven-pharma.com
Site:49-Km Lahore Multan Road, Pakistan.
Date: March 09, 2026 To
Mr. Hafiz Maqsood Munshi
Unit Head - Listed Companies Compliance Regulatory Affairs Division
Pakistan Stock Exchange Limited
Subject: Response to Notice - Non-Submission of Mandatory Shariah Disclosures Dear Sir,
We acknowledge receipt of your notice Ref. No. PSX/Gen-292 dated March 04, 2026 regarding the non-submission of Shariah disclosures in the half-yearly condensed interim financial statements of Liven Pharma Limited for the period ended December 31, 2025.
In this regard, we respectfully submit that the omission occurred due to our interpretation of the applicable disclosure requirements. The Company's half-yearly financial statements are prepared and disseminated as condensed interim financial statements, which primarily include selected explanatory notes. As reflected in the annual financial statements for the year ended June 30, 2025, the Company has disclosed the Shariah-compliant disclosure as Note No. 47.
Based on this understanding, it was considered that the detailed disclosures relating to Shariah-compliant and non-Shariah-compliant income were not required to be presented in the interim condensed financial statements.
In light of the clarification received through your letter, the Company has incorporated the required Shariah disclosures as Note No. 24 in the half-yearly condensed interim financial statements for the period ended December 31, 2025. The half-yearly condensed interim financial statements along with the relevant disclosure are enclosed herewith for your review.
The Company sincerely regrets this inadvertent omission and assures you of its full commitment to compliance with all applicable regulatory requirements of the Pakistan Stock Exchange. Necessary measures have been taken to ensure that the required Shariah disclosures will be appropriately included in all future financial reporting.
Should you require any further information or clarification, we shall be pleased to provide the same.
Yours sincerely,
For and on behalf ofLiven Pharma Limited
Company Secretary
Muhammad Saeed
L i v e W i t h H e a l t h
1 | Sharia Compliant Disclosure
1 | Review Report and Half Yearly Finanical Statements 2025CONDENSED INTERIM FINANCIAL STATEMENTS FOR THE HALF YEAR ENDED DECEMBER 31, 2025.
4 9 K M L A H O R E M U L T A N R O A D P A K I S T A N
w w w . l i v e n- p h a rm a . c o m i n f o @ l i v e n - p h a r m a . c o m
+ 9 2 - 3 - 1 1 1 - 0 - L I V E N
Table of contentsReport on Review of Interim Financial Statements 3
CONDENSED INTERIM FINANCIAL STATEMENTS FOR THE HALF YEAR ENDED DECEMBER 31, 2025 4